Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Insurance Companies Must Not Take Shortcuts with Medicare Advantage Record Keeping

Medicare Advantage has allegedly overcharged Medicare by $1,000 per policyholder. Melanie Musson, an insurance expert with ExpertInsuranceReviews.com, says, “Medicare Advantage insurance providers must prepare to justify their charges by keeping accurate records and documentation.” Medicare Advantage plans are increasing in popularity, but this private insurance alternative to government-run Original Medicare must be careful to be…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Start free

Medicare Advantage has allegedly overcharged Medicare by $1,000 per policyholder. Melanie Musson, an insurance expert with ExpertInsuranceReviews.com, says, “Medicare Advantage insurance providers must prepare to justify their charges by keeping accurate records and documentation.”

Medicare Advantage plans are increasing in popularity, but this private insurance alternative to government-run Original Medicare must be careful to be transparent or keep accurate records, or they’ll pay the price.

Kaiser Health News recently reported on a trend of Medicare Advantage providers dodging auditors and overcharging taxpayers through billing Medicare.

Medicare Advantage Audit Failures Are Nothing New

In 2011, Blue Cross of Minnesota couldn’t locate records of podiatry patients who were treated at a podiatry clinic accepting Medicare. Federal audits revealed a combined care cost that exceeded $20,000. Due to circumstances surrounding that case and the podiatry clinic facing fraud allegations, the insurance provider was granted a hardship exemption.

But as demands for transparency increase, these exemptions may be harder to obtain, making it vitally important for Medicare Advantage providers to keep their own records and not depend on healthcare providers to give them documentation if needed for an audit.

The Cost of Medicare Advantage Failures

Medicare Advantage plans charge policyholders a premium, and they work with Medicare for payment for Medicare-covered services. Federal audits revealed that Medicare Advantage plans had overcharged Medicare for services averaging $1,000 per Medicare Advantage policyholder.

That equates to millions of dollars overcharged to Medicare. Those costs are passed down to taxpayers.

Medicare Advantage Should Prepare for More Oversight

The federal government has been working to demand repayment for overcharges from Medicare Advantage plan providers. So, these providers must prepare to back up all their charges with the proper documentation to avoid additional repayments or penalties.

Car insurance providers proved their commitment to fair compensation by issuing auto insurance givebacks in the midst of COVID-19 shutdowns. Medicare Advantage providers should take note and prepare to pay back the federal government if necessary.

Whether or not Medicare Advantage actually overcharged Medicare and, thereby, American Taxpayers is a moot point. With proper documentation and record-keeping, insurance providers can prove the legitimacy of their charges.

Medicare Advantage providers must resist the urge to save money by cutting corners and must instead keep organized records and follow the governmental red tape associated with the medicare program.

By doing so, insurance providers can protect themselves and regain the trust of their policyholders and the American taxpayers.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free plan

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale workspace, up to 10 people
One professional video edit a month for qualifying companies
Media requests to your crowd, remote recording, AI writing tools
$0, no credit card, nothing that expires

More Healthcare Insights

NICE recommends Enhertu for HER2-low advanced breast cancer in England

NICE recommends Enhertu for HER2-low advanced breast cancer in England

American Pharmaceutical Review reported that NICE has recommended Enhertu for routine NHS use in people with HER2-low advanced breast cancer, following a commercial agreement and updates to NICE’s methods under the U.K.-U.S. Pharmaceutical Pricing Agreement.

  • 01NICE tied the reversal to 2026 changes: higher cost-effectiveness thresholds that took effect in April and a new quality-of-life assessment method published Aug. 27, 2026.
  • 02Access planning still varies by nation: Fierce Pharma reported Wales requires funding within 60 days of final guidance, while Scotland and Northern Ireland follow separate processes.

Sep 21, 2026

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly’s $6.5B Houston Bet Highlights U.S. Pharma Reshoring

Eli Lilly has broken ground on a $6.5 billion manufacturing facility in Houston, slated for completion around 2030. While attention has focused on scaling production of Foundayo, its oral GLP-1 treatment, the project also reflects broader U.S. efforts to rebuild domestic pharmaceutical manufacturing and highlights the supply chain challenge of forecasting demand and building capacity years in advance.

  • 01Eli Lilly commits $6.5 billion to a Houston pharmaceutical manufacturing facility due for completion around 2030, one of the largest single U.S. pharma production investments in recent years
  • 02GLP-1 demand forecasting remains highly uncertain, making it difficult to commit billions to manufacturing capacity years before demand and required output are clear.
  • 03Houston's selection reflects industrial capacity and workforce depth, positioning the region as a biomanufacturing corridor and creating long-term hiring demand in engineering, quality control, and skilled trades

Sep 21, 2026

NextGen Invent’s Deepak Mittal argues for scoped healthcare AI pilots with early governance

NextGen Invent’s Deepak Mittal argues that healthcare AI pilots can begin with a reliable data subset and early governance. His performance figures are vendor claims, not independently verified results.

  • 01Deepak Mittal advocates starting with a defined problem and suitable data rather than waiting for perfect organization-wide data.
  • 02Some performance figures cited in the interview (for example, preparation time and model counts) are company-reported and not independently verified in this article.
  • 03NIST’s voluntary AI Risk Management Framework provides an independent structure for governance and risk evaluation.

Sep 21, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512